## MET: MetLife, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.66 indicates fundamental undervaluation.

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($79.06)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. MetLife gets positive feedback from analysts**
- Source: MSN | 20251210T090809 | Bullish | Relevance: 100%
- This article reports that MetLife has received positive feedback from analysts. No further details are available regarding the nature of the feedback or the specific analysts involved.

**2. Occudo Quantitative Strategies LP Acquires Shares of 102,933 MetLife, Inc. $MET**
- Source: MarketBeat | 20251212T125844 | Somewhat-Bullish | Relevance: 100%
- Occudo Quantitative Strategies LP has acquired 102,933 shares of MetLife, Inc. (NYSE:MET) during the second quarter, valuing their new position at approximately $8.278 million, making MetLife its 17th biggest holding. Other institutional investors have also adjusted their stakes in MetLife, which has received a "Moderate Buy" consensus rating from analysts. The financial services provider recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.

**3. State Street Corp Has $2.09 Billion Stock Holdings in MetLife, Inc. $MET**
- Source: MarketBeat | 20251211T115010 | Somewhat-Bullish | Relevance: 100%
- State Street Corp reduced its stake in MetLife, Inc. by 2.9% in the 2nd quarter, now holding 26,030,065 shares valued at $2.09 billion, representing approximately 3.91% of MetLife. Other institutional investors also adjusted their positions, and 94.99% of MetLife stock is currently owned by institutional investors. MetLife recently announced a quarterly dividend of $0.5675, amounting to an annualized dividend of $2.27 and a yield of 2.8%.

**4. iSAM Funds UK Ltd Buys New Shares in MetLife, Inc. $MET**
- Source: MarketBeat | 20251210T120959 | Somewhat-Bullish | Relevance: 100%
- iSAM Funds UK Ltd has acquired a new position in MetLife, Inc. (NYSE:MET), purchasing 18,327 shares valued at approximately $1.47 million. Several other hedge funds have also adjusted their holdings in MetLife, which recently announced a quarterly dividend and whose stock currently has a "Moderate Buy" consensus rating from analysts with an average price target of $94.60.

**5. Lombard Odier Asset Management Switzerland SA Has $2.58 Million Stake in MetLife, Inc. $MET**
- Source: MarketBeat | 20251210T120925 | Somewhat-Bullish | Relevance: 100%
- Lombard Odier Asset Management Switzerland SA increased its stake in MetLife, Inc. (NYSE:MET) by 75.4% in the second quarter, bringing its total holdings to 32,071 shares valued at approximately $2.58 million. Other institutional investors, including Norges Bank and ABN AMRO, also made significant investments, resulting in institutional ownership of 94.99% of MetLife's stock. MetLife reported strong Q3 earnings, beating EPS estimates, and pays an annualized dividend of $2.27, yielding 2.9%.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 11 ($0.34M) |
| Sells | 1 ($0.35M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+13.3%)
- Dodge & Cox Inc.: 8.1% (+0.9%)
- Blackrock Inc.: 7.4% (+2.2%)
- State Street Corpora: 3.9% (-1.3%)
- Price (T.Rowe) Assoc: 3.1% (+1.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +6.5% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.66 indicates undervaluation relative to growth. Forward P/E 8.2x attractive for 15% earnings growth. Balance sheet: strong liquidity (432.0x). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $54.6B |
| Beta | 0.76 |
| 52W Range | $65.21 - $88.09 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.66 |
| Forward P/E | 8.2 |
| Current P/E | 9.4 |
| YoY Growth | 15.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.4% to 6.0% (+6.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 81st percentile. MRS_5 at 4.1% confirms short-term momentum alignment. AM_20 at 6.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.75), confirming momentum. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.04% (CS: 81) | Strong |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 0.75 | Bullish |
| vs SMA20 | 1.064x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.046x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $82.16
- **Stop Loss:** $79.06 (3.8% risk)
- **Target:** $88.36 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 387
- **Position Value:** $31,795.92
- **Portfolio %:** 31.80%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-04 (Est: $2.36)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.32 | $2.37 | +2.2% |
| 2025Q2 | $2.16 | $2.02 | -6.7% |
| 2025Q1 | $2.01 | $1.96 | -2.5% |
| 2024Q4 | $2.09 | $2.09 | -0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*